Last reviewed · How we verify
NCT06095349: FORST3
Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.
NA trial testing inhalatory treatment with sulfureous aerosol in Hydrogen Sulfide in 50 participants. Completed in 30 November 2023.
30 November 2023
Quick facts
| Lead sponsor | Istituto Ortopedico Rizzoli |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 1 October 2019 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- inhalatory treatment with sulfureous aerosol
Conditions studied
- Hydrogen Sulfide — all drugs for Hydrogen Sulfide →
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Istituto Ortopedico Rizzoli — full company profile →
Who can join
Adults 50 to 60, female only, with Hydrogen Sulfide or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to investigate whether inhalation treatment with high-sulfide waters from some spas (referred to as "thermal waters"), performed for 12 consecutive days, is able to change circulating H2S levels and alter bone metabolism. Identifying a clear correlation between circulating levels of H2S and sulfur water administration, as well as a potential anabolic effect on bone, would set the stage for new studies that could have important clinical implications for promoting health and preventing osteoporosis
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Reactive Sulfur Species and Protein Persulfidation: An Emerging Redox Axis in Human Health and Disease.
Andrés CMC, Lobo F, Lastra JMP, Munguira EB, et al · · 2025 · cited 7× · PMID 41020887 · DOI 10.3390/cimb47090765 -
Changes in Oxidative Stress, Inflammatory and Bone Metabolism Biomarkers Following Sulfurous Water Inhalation in Osteopenic Women.
Gambari L, Amore E, Roseti L, Carpentieri S, et al · · 2026 · PMID 41977347 · DOI 10.3390/ijms27073163
Verify or expand the search:
- PubMed search for NCT06095349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hydrogen Sulfide
Currently open trials in the same condition.
- NCT06802276 — Smart Underwear to Measure Diet-Induced Hydrogen Sulfide Production · NA · recruiting
Other Istituto Ortopedico Rizzoli trials
Trials by the same sponsor.
- NCT07590882 — Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study · enrolling by invitation
- NCT07021222 — Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaF · NA · recruiting
- NCT07360964 — Clear Cell Chondrosarcoma in Italy · NA · active not recruiting
- NCT07140367 — "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology" · recruiting
- NCT07102875 — Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06095349 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Ortopedico Rizzoli
- Last refreshed: 19 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing